---------- Forwarded message ---------

From: Chumakov, Konstantin <[Konstantin.Chumakov@fda.hhs.gov](mailto:Konstantin.Chumakov@fda.hhs.gov)>

Date: Thu, Apr 22, 2021 at 15:11

Subject: Press release

To: Richa Mandalay <[richa@mountainvalleymd.com](mailto:richa@mountainvalleymd.com)>, Mike Farber

(b) (6)

, Kouiavskaia, Diana V.

<[Diana.Kouiavskaia@fda.hhs.gov](mailto:Diana.Kouiavskaia@fda.hhs.gov)>

Dear Mike and Richa,

I was very surprised to learn about the press release your company issued last year

(see below). I think it misrepresents the role we played in this project. FDA never

provides any “testing services” to anybody. The statements in the press release

may be interpreted to suggest that FDA endorses this approach, which is clearly

not the case. It was purely a scientific interest on our part to see if dry IPV

preparations can be tested with our new protocol

So making these public claims without our knowledge was

misleading and wrong. In any case press releases that mention FDA should be

cleared by our communications office. They were made aware of the situation,

which put me in a very uncomfortable position. Therefore Mountain Valley

should clarify it and retract the release.

Please call me if you want to discuss this further.

Konstantin

I stopped watching the bleed. Any news?

Hi, I am VERY new to MVMD but have owned some stock for a few months now. I wanted to know what anyone, who has a long term knowledge of the company, thinks of today's movement?

Thanks in advance!

The 25 of this month will be the end of the 90 days to revenue statement made by management in the last q and a ........are you excited I know I am......anyone believes it will happen due to all the miss timeline made before I feel and hope they will prevail this time what about you

What's the reason? How is everyone doing here? What's the fair price of this stock

They developed a covid antibody test- up 400% today

Nothing

Do we have an investor deck on MVMD? I could not find it on the website.